leadf
logo-loader

Buds & Duds: Cannabis stocks sputter to open the week but GW Pharmaceutical rises on Buy rating

The sector struggled overall, but a couple companies made headway on positive news

Cannabis stocks dropping graphic
GW Pharmaceuticals shares increased after Needham & Co initiated coverage of the stock with a Buy rating and a $200 price target.

Cannabis stocks on Monday continued on their downward trend.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 2% to 136.54 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 1.5% to C$10.44, while the OTCQX Cannabis Index sank 2.1% to 497 points.

Buds

Despite trouble for the sector, a few marijuana stocks managed to sneak into positive territory.

GW Pharmaceuticals plc (NASDAQ:GWPH) shares increased after analysts at Needham & Co initiated coverage of the stock with a Buy rating and a $200 price target. 

Shares climbed almost 3% to US$121.49. 

MariMed Inc (OTCMKTS:MRMD) announced the acquisition of two of its cannabis-licensed clients in Illinois, KPG Anna and KPG Harrisburg.

Traders liked the consolidation, sending shares 5.4% higher to US$0.78.

Meanwhile, Tilray Inc (NASDAQ:TLRY) rose 1.1% to $21.60; ICC International Cannabis Corp (CSE:WRLD.U) (OTCMKTS:WLDCF) jumped 14% to C$0.04 in Toronto and 12% to US0.04 in New York; and 1933 Industries Inc increased 1.4% to US$0.20 on OTC Markets.

Duds

Among those driving the industry down, General Cannabis Corp (OTCMKTS:CANN) lost 8.3% to trade at US$0.58.

Terra Tech Corp (OTCMKTS:TRTC) fell 7.1% to US$0.26, while Origin House (CSE:OH) (OTCMKTS:ORHOF) dropped nearly 8% to C$6.35 on the CSE and nearly 7% to US$4.84 on OTC Markets.

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com 

Follow him on Twitter @andrew_kessel

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Adastra Labs state of the art facility just one of the advantages the...

Adastra Labs (CSE: XTRX) CEO Andy Hale joined Steve Darling from Proactive to share details about the cannabis processing and analytical testing services company. Hale discusses their state-of-the-art facility in Langley, British Columbia and the new equipment they are installing. Hale also...

17 hours, 53 minutes ago

2 min read